UK and US : biotech ##nology Orchard ##tech has secured funding of $ 150 m to expand its work in gene therapy . The financing followed the company ’s acquisition in April of hp ’s portfolio of rare disease gene therapies , and builds on previous investments of $ 140 m .
UK and US based biotech firm Orchard Therapeutics has secured funding of $150m to expand its work in gene therapy. The financing followed the company’s acquisition in April of GlaxoSmithKline’s portfolio of rare disease gene therapies, and builds on previous financing of $140m.